MARCHF10-DT
gene geneOn this page
Summary
MARCHF10-DT (MARCHF10 divergent transcript, HGNC:52815) is a long non-coding RNA gene on chromosome 17q23.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52815 |
| Approved symbol | MARCHF10-DT |
| Name | MARCHF10 divergent transcript |
| Location | 17q23.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000265000 |
| Ensembl biotype | lncRNA |
| Entrez | 101927877 |
| RNAcentral | URS0000A76FE5 — lncRNA, 1809 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000584542, ENST00000828972
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000584542 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002688418 | 62835013 | 62836371 |
| ENSE00002715768 | 62808500 | 62808951 |
Expression profiles
Bgee: expression breadth broad, 16 present calls, max score 83.96.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1646 / max 9.0640, expressed in 92 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 162142 | 0.1646 | 92 |
Top tissues by expression
163 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.86 | gold quality |
| oocyte | CL:0000023 | 62.53 | gold quality |
| heart right ventricle | UBERON:0002080 | 59.64 | gold quality |
| sperm | CL:0000019 | 57.81 | gold quality |
| buccal mucosa cell | CL:0002336 | 56.52 | gold quality |
| superficial temporal artery | UBERON:0001614 | 54.57 | gold quality |
| amniotic fluid | UBERON:0000173 | 53.54 | gold quality |
| seminal vesicle | UBERON:0000998 | 53.18 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 53.01 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 52.99 | gold quality |
| primary visual cortex | UBERON:0002436 | 52.56 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 52.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 51.92 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 51.29 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 51.19 | gold quality |
| vastus lateralis | UBERON:0001379 | 50.88 | gold quality |
| cardiac ventricle | UBERON:0002082 | 50.83 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.64 | gold quality |
| heart left ventricle | UBERON:0002084 | 49.62 | gold quality |
| biceps brachii | UBERON:0001507 | 49.36 | gold quality |
| upper leg skin | UBERON:0004262 | 48.48 | silver quality |
| blood | UBERON:0000178 | 48.39 | gold quality |
| occipital lobe | UBERON:0002021 | 48.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 47.64 | gold quality |
| islet of Langerhans | UBERON:0000006 | 47.56 | silver quality |
| heart | UBERON:0000948 | 47.42 | gold quality |
| bronchial epithelial cell | CL:0002328 | 46.60 | gold quality |
| skin of hip | UBERON:0001554 | 46.54 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 46.29 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.45 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.